400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / JAK/STAT Signaling / STAT / 6-硝基苯并[b] 噻吩-1,1-二氧化物
CAS No.: 19983-44-9
Synonyms: STAT3 Inhibitor V
Stattic, a nonpeptidic small molecule, potently inhibits STAT3 activation and nuclear translocation with IC50 of 5.1 μM in cell-free assays, highly selectivity over STAT1.
生物活性
靶点 | STAT3 IC50:5.1μM |
实验方案
技术信息
CAS号 | 19983-44-9 | 储存条件 |
|
|||||||||||
分子式 | C8H5NO4S | 运输 | 蓝冰 | |||||||||||
分子量 | 211.19 | 别名 | STAT3 Inhibitor V | |||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
A431 | 2 μM | Growth Inhibition Assay | 2 h | blocks EGF-reversed decreases in cell viability | 25720435 |
A431 | 2 μM | Growth Inhibition Assay | 2 h | increases in apoptosis induced by shikonin | 25720435 |
C13* | 0-10 μM | Apoptosis Assay | 24/48 h | induces apoptosis in a dose and time dependent manner | 23962558 |
C13* | - | Apoptosis Assay | 24/48 h | enhances cisplatin-induced apoptosis | 23962558 |
C666-1 | 0.5-64 μM | Cell Viability Assay | 48 h | suppresses cell viability in a dose- and time-dependent manner | 23382914 |
C666-1 | 1/2 μM | Cell Viability Assay | 48 h | sensitize cells to radiotherapy | 23382914 |
Caki-1 | 10 µM | Growth Inhibition Assay | 20 min | enhances sorafenib- and sunitinib-induced growth inhibition | 25013907 |
Cal33 | - | Growth Inhibition Assay | - | IC50=2.282 ± 0.423 μM, GI50=1.349 ± 0.363 μM | 22770899 |
Cal33 | 0-30 μM | Function Assay | 0-24 h | inhibits STAT3 activation dose and time dependently | 22770899 |
CD4+ | 10 μm | Apoptosis Assay | 24 h | induces apoptosis strongly | 24756111 |
CNE1 | 20 µM | Function Assay | 48 h | blocks the IL-6 increased phosphorylation of Stat3 | 23382914 |
CNE1 | 4 μM | Growth Inhibition Assay | - | significantly reduces cell viability | 23382914 |
CNE1 | 0-20 μM | Function Assay | 0-4 h | inhibits Stat3 activation in a dose- and time-dependent manner | 23382914 |
CNE1 | 0.5-64 μM | Cell Viability Assay | 48 h | suppresses cell viability in a dose- and time-dependent manner | 23382914 |
CNE1 | 10 µM | Apoptosis Assay | 48 h | induces apoptosis | 23382914 |
CNE2 | 20 µM | Function Assay | 48 h | blocks the IL-6 increased phosphorylation of Stat3 | 23382914 |
CNE2 | 0-20 μM | Function Assay | 0-4 h | inhibits Stat3 activation in a dose- and time-dependent manner | 23382914 |
CNE2 | 0.5-64 μM | Cell Viability Assay | 48 h | suppresses cell viability in a dose- and time-dependent manner | 23382914 |
CNE2 | 10 µM | Apoptosis Assay | 48 h | induces apoptosis | 23382914 |
CNE2 | 1/2 μM | Cell Viability Assay | 48 h | sensitize cells to radiotherapy | 23382914 |
CT26 | 20 mM | Function Assay | 1 h | suppresses HGF-induced VEGF expression | 23233163 |
DLD-1 | 5/10/20 μM | Cell Viability Assay | 72 h | inhibits cell viability of the ALDH+/CD133+ cells | 21900397 |
ECA109 | 0-20 μM | Growth Inhibition Assay | 24 h | IC50=5.50 μM | 25492480 |
ECA109 | 0.5 μM | Clonogenic Survival Assay | 24 h | suppresses the clonogenic formation | 25492480 |
ECA109 | 0.5 μM | Function Assay | 24 h | enhances IR-induced generation of DSBs | 25492480 |
ELL-primed hNSCs | 0.02-5 μM | Cell Viability Assay | 72 h | leads to the loss of cell viability at high concentration | 24945434 |
FHL-primed hNSCs | 0.02-5 μM | Cell Viability Assay | 72 h | leads to the loss of cell viability at high concentration | 24945434 |
H9c2 | 10 μM | Function Assay | 4 h | reverses the effects of IL-27 | 26339633 |
H9c2 | 2/10 μM | Function Assay | 2 h | abrogates the cytoprotective effects of IL-27 against SH | 25820907 |
H9c2 | 20 µM | Function Assay | 30 min | abolishes propofol-induced AKT phosphorylation at both ser473 and thr308 | 25105067 |
HaCaT | 10 µM | Growth Inhibition Assay | 20 min | enhances sorafenib- and sunitinib-induced growth inhibition | 25013907 |
HaCaT | 10 µM | Apoptosis Assay | 20 min | increases proportions of apoptotic cells due to treatment with sorafenib or sunitinib | 25013907 |
HaCaT | 10 µM | Growth Inhibition Assay | 20 min | enhances everolimus-induced cell growth inhibition | 24423131 |
HaCaT | 10 µM | Apoptosis Assay | 20 min | enhances the apoptotic effects of everolimus | 24423131 |
HASMC | 1.25-5 μM | Function Assay | 20 min | inhibits p-(Y)-STAT-1,3,5 signals | 25849622 |
HCT116 | 5/10/20 μM | Cell Viability Assay | 72 h | inhibits cell viability of the ALDH+/CD133+ cells | 21900397 |
HEC-1A | 1 μM | Function Assay | 24 h | blocks the MUC20-enhanced invasion triggered by 10% FBS | 23262208 |
HEC-1A | 1 μM | Function Assay | 24 h | blocks the MUC20-enhanced invasion triggered by EGF | 23262208 |
HepG2 | 20 μM | Cell Viability Assay | 24 h | reduces cell viability | 21311975 |
HMECs | 10 μM | Function Assay | 2 h | inhibits IFNα mediated phosphorylation of STAT1, STAT2 and STAT3 | 24211327 |
HONE1 | 20 µM | Function Assay | 48 h | blocks the IL-6 increased phosphorylation of Stat3 | 23382914 |
HONE1 | 0-20 μM | Function Assay | 0-4 h | inhibits Stat3 activation in a dose- and time-dependent manner | 23382914 |
HONE1 | 0.5-64 μM | Cell Viability Assay | 48 h | suppresses cell viability in a dose- and time-dependent manner | 23382914 |
HONE1 | 10 µM | Apoptosis Assay | 48 h | induces apoptosis | 23382914 |
HONE1 | 1/2 μM | Cell Viability Assay | 48 h | sensitize cells to radiotherapy | 23382914 |
HTR8/SVneo | 1 μM | Function Assay | 1 h | suppressed OSM-induced STAT3 phosphorylation | 24060241 |
HTR8/SVneo | 0.5/1 μM | Function Assay | 48 h | restores the expression of E-cadherin suppressed by OSM | 24060241 |
HTR8/SVneo | 1 μM | Function Assay | 48 h | significantly increases migration by OSM | 24060241 |
Huh-7 | 20 μM | Cell Viability Assay | 24 h | reduces cell viability | 21311975 |
HuT-78 | 1-10 μM | Cell Viability Assay | 72 h | causes a dose-dependent inhibition of the viability | 24756111 |
KYSE150 | 0-20 μM | Growth Inhibition Assay | 24 h | IC50=12.64 μM | 25492480 |
KYSE150 | 0.5 μM | Clonogenic Survival Assay | 24 h | suppresses the clonogenic formation | 25492480 |
MCF-7 | 0.469-3.75 μM | Growth Inhibition Assay | 5 d | reduces cell number significantly | 24728078 |
MCF-7/LCC1 | 0.469-3.75 μM | Growth Inhibition Assay | 5 d | reduces cell number significantly | 24728078 |
MCF-7/LCC9 | 0.469-3.75 μM | Growth Inhibition Assay | 5 d | reduces cell number significantly | 24728078 |
MCF7-HER2 | 0-10 μM | Growth Inhibition Assay | 48 h | induces cell death dose dependently | 24297508 |
MCF7-HER2 | 5 μM | Function Assay | 24 h | diminishes Sox-2, Oct-4, and slug expression | 24297508 |
MCF7-HER2 | 5 μM | Function Assay | 24 h | decreases the expression levels of EMT markers, vimentin and slug | 24297508 |
MCF7-HER2 | 5 μM | Growth Inhibition Assay | 24 h | enhances cell growth inhibition combined with Herceptin | 24297508 |
MDA-MB-231 | 20 μM | Function Assay | 2 h | exhibits Snail and E-cadherin expression | 25153349 |
MDA-MB-231 | 10 µM | Function Assay | 24 h | reduces P-STAT3 expression | 24376586 |
MDA-MB-231 | 10 μM | Apoptosis Assay | 24 h | induces apoptosis | 17114005 |
MDA-MB-435S | 10 μM | Apoptosis Assay | 24 h | induces apoptosis | 17114005 |
Neuro-2a | 0-10 μM | Cell Viability Assay | 72 h | inhibits cell viability dose dependently | 25436682 |
NPC | 0-7.5 µM | Function Assay | - | abolishes EMT-like molecular alterations, and cell migration and invasion induced by RKIP knockdown | 25915430 |
OSC-19 | - | Growth Inhibition Assay | - | IC50=3.481 ± 0.953 μM, GI50=1.366 ± 0.770 μM | 22770899 |
OSC-19 | 0-30 μM | Function Assay | 0-24 h | inhibits STAT3 activation dose and time dependently | 22770899 |
OV2008 | 0-10 μM | Apoptosis Assay | 24/48 h | induces apoptosis in a dose and time dependent manner | 23962558 |
OV2008 | - | Apoptosis Assay | 24/48 h | enhances cisplatin-induced apoptosis | 23962558 |
PC3M-1E8 | 2.5/5/10 μM | Function Assay | 0-4 h | inhibits the STAT3 activation in a dose- and time-dependent manner | 25261365 |
PC3M-1E8 | 10 μM | Function Assay | 24 h | downregulates Bcl-xL, survivin and c-Myc | 25261365 |
PC3M-1E8 | 10 μM | Function Assay | 24 h | inhibits IL-6 induced STAT3 activation and the IL-6-induced STAT3 activation | 25261365 |
PC3M-1E8 | 2.5/5/10 μM | Clonogenic Survival Assay | - | inhibits the colony formation significantly | 25261365 |
PCNs | 0-10 μM | Cell Viability Assay | 72 h | inhibits cell viability dose dependently | 25436682 |
PGCs | 0-10 μM | Cell Viability Assay | 72 h | inhibits cell viability dose dependently | 25436682 |
RAW264.7 | 10 μM | Function Assay | 12 h | abrogates the mRNA expressions of JAK2, STAT1, STAT2, and STAT3 induced by DON and T-2 toxin | 22454431 |
RAW264.7 | 5/10 μM | Apoptosis Assay | 45 min | enhances toxins induced apoptosis and MMP loss | 22454431 |
RL95-2 | 1 μM | Function Assay | 24 h | blocks the MUC20-enhanced invasion triggered by 10% FBS | 23262208 |
RL95-2 | 1 μM | Function Assay | 24 h | blocks the MUC20-enhanced invasion triggered by EGF | 23262208 |
SeAx | 1-10 μM | Cell Viability Assay | 72 h | causes a dose-dependent inhibition of the viability | 24756111 |
SH-SY5Y | 0-10 μM | Cell Viability Assay | 72 h | inhibits cell viability dose dependently | 25436682 |
SiHa | 5-75 nM | Cell Viability Assay | 24 h | shows morphology of a typical apoptotic cell and dose-dependent loss of cell viability | 25539644 |
SiHa | 5-75 nM | Function Assay | 24 h | reduces the phosphorylation at the tyrosine residue 705 | 25539644 |
SK-BR-3 | 10 µM | Function Assay | 24 h | reduces P-STAT3 expression | 24376586 |
SNU387 | 20 μM | Cell Viability Assay | 24 h | reduces cell viability | 21311975 |
SNU398 | 20 μM | Cell Viability Assay | 24 h | reduces cell viability | 21311975 |
SS | 1-10 μM | Cell Viability Assay | 72 h | causes a dose-dependent inhibition of the viability | 24756111 |
SUM-159 | 10 µM | Function Assay | 24 h | reduces P-STAT3 expression | 24376586 |
SW480 | 5/10/20 μM | Cell Viability Assay | 72 h | inhibits cell viability of the ALDH+/CD133+ cells | 21900397 |
SW837 | 2.5/10 μM | Function Assay | 30 min | sensitizes cells to chemoradiotherapy in a dose-dependent manner | 23934972 |
T24 | 2/10/20 μM | Function Assay | 24 h | causes dose-dependent inhibition of the CXCL12-induced increase of invading cells | 23526079 |
TE13 | 0-20 μM | Growth Inhibition Assay | 24 h | IC50=6.15 μM | 25492480 |
TE13 | 0.5 μM | Clonogenic Survival Assay | 24 h | suppresses the clonogenic formation | 25492480 |
Tu-9648 | 0-10 μM | Cell Viability Assay | 72 h | inhibits cell viability dose dependently | 25436682 |
U-373MG | 0-10 μM | Cell Viability Assay | 72 h | inhibits cell viability dose dependently | 25436682 |
U-87MG | 0-10 μM | Cell Viability Assay | 72 h | inhibits cell viability dose dependently | 25436682 |
UM-SCC-17B | - | Growth Inhibition Assay | - | IC50=2.562 ± 0.409 μM, GI50=1.279 ± 0.194 μM | 22770899 |
UM-SCC-17B | 0-30 μM | Function Assay | 0-24 h | inhibits STAT3 activation dose and time dependently | 22770899 |
UM-SCC-22B | - | Growth Inhibition Assay | - | IC50=2.648 ± 0.542 μM, GI50=1.320 ± 0.204 μM | 22770899 |
UM-SCC-22B | 0-30 μM | Function Assay | 0-24 h | inhibits STAT3 activation dose and time dependently | 22770899 |
VSMC | 3/5/10 μM | Growth Inhibition Assay | 30 min | prevents PDGF- and thrombin-mediated VSMC proliferation in a dose-dependent manner | 20847306 |
W480 | 2.5/10 μM | Function Assay | 30 min | sensitizes cells to chemoradiotherapy in a dose-dependent manner | 23934972 |
靶点 | Description | IC50 |
---|---|---|
STAT3 | IC50:5.1μM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网